BTIG Downgrades Sionna Therapeutics (SION) to Neutral, 'we were wrong on our PreciSION CF call'
Tweet Send to a Friend
BTIG analyst Kambiz Yazdi downgraded Sionna Therapeutics (NASDAQ: SION) from Buy to Neutral.The analyst comments "We will be straightforward: we ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
